Pain therapy with oxycodone/naloxone prolonged-release combination: case report
Pain afflicts patients suffering from many chronic diseases and is present in 80% of cases of patients with advanced cancer who suffer from persistent pain. The aim of the pain treatment is to achieve the maximum analgesic effect while minimizing side effects. The main analgesic agent – morphine is...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Termedia Publishing House
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934054/ |
| id |
pubmed-3934054 |
|---|---|
| recordtype |
oai_dc |
| spelling |
pubmed-39340542014-03-03 Pain therapy with oxycodone/naloxone prolonged-release combination: case report Błaszczyk, Feliks Droń, Aleksandra Case Report Pain afflicts patients suffering from many chronic diseases and is present in 80% of cases of patients with advanced cancer who suffer from persistent pain. The aim of the pain treatment is to achieve the maximum analgesic effect while minimizing side effects. The main analgesic agent – morphine is unfortunately a therapy associated with gastrointestinal side effects. It appears that the combination of oxycodone and naloxone available as Targin® (Mundipharma) is an alternative. The paper presents a case of a 45-year-old patient who was treated effectively with oxycodone/naloxone prolonged-release tablets. This treatment has proven to be effective in providing pain and constipation control. Termedia Publishing House 2013-10-07 2013 /pmc/articles/PMC3934054/ /pubmed/24592131 http://dx.doi.org/10.5114/wo.2013.37911 Text en Copyright © 2013 Termedia http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| repository_type |
Open Access Journal |
| institution_category |
Foreign Institution |
| institution |
US National Center for Biotechnology Information |
| building |
NCBI PubMed |
| collection |
Online Access |
| language |
English |
| format |
Online |
| author |
Błaszczyk, Feliks Droń, Aleksandra |
| spellingShingle |
Błaszczyk, Feliks Droń, Aleksandra Pain therapy with oxycodone/naloxone prolonged-release combination: case report |
| author_facet |
Błaszczyk, Feliks Droń, Aleksandra |
| author_sort |
Błaszczyk, Feliks |
| title |
Pain therapy with oxycodone/naloxone prolonged-release combination: case report |
| title_short |
Pain therapy with oxycodone/naloxone prolonged-release combination: case report |
| title_full |
Pain therapy with oxycodone/naloxone prolonged-release combination: case report |
| title_fullStr |
Pain therapy with oxycodone/naloxone prolonged-release combination: case report |
| title_full_unstemmed |
Pain therapy with oxycodone/naloxone prolonged-release combination: case report |
| title_sort |
pain therapy with oxycodone/naloxone prolonged-release combination: case report |
| description |
Pain afflicts patients suffering from many chronic diseases and is present in 80% of cases of patients with advanced cancer who suffer from persistent pain. The aim of the pain treatment is to achieve the maximum analgesic effect while minimizing side effects. The main analgesic agent – morphine is unfortunately a therapy associated with gastrointestinal side effects. It appears that the combination of oxycodone and naloxone available as Targin® (Mundipharma) is an alternative. The paper presents a case of a 45-year-old patient who was treated effectively with oxycodone/naloxone prolonged-release tablets. This treatment has proven to be effective in providing pain and constipation control. |
| publisher |
Termedia Publishing House |
| publishDate |
2013 |
| url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934054/ |
| _version_ |
1612061668221648896 |